Patents for A61K 49 - Preparations for testing in vivo (35,376)
03/2013
03/13/2013CN102166189B Targeted and fluorescence dual-functional slightly-soluble antitumor medicament nano structural lipid carrier
03/13/2013CN101920023B Transrectal ultrasound medical coupling agent
03/13/2013CN101505714B Use of a composition for skin treatment under X-irradiation
03/13/2013CN101421323B Loaded latex optical molecular imaging probes
03/12/2013US8394389 Tuberculosis vaccine and method of using same
03/12/2013US8394356 Diagnostic imaging contrast agents with extended blood retention
03/12/2013US8394355 Use of UTP for the diagnosis of stenoses and other conditions of restricted blood flow
03/12/2013CA2727803C Metal abstraction peptide (map) tag and associated methods
03/12/2013CA2587335C Compositions, systems and methods for treatment of defects in blood vessels
03/12/2013CA2454421C Use of long pentraxin ptx3 for treating female infertility
03/12/2013CA2407910C Antibodies that immunospecifically bind to blys
03/07/2013WO2013032946A1 Contrast assisted intravascular ultrasound imaging
03/07/2013WO2013029139A1 Fluorescent polyaniline nanoparticles
03/07/2013WO2013009475A9 Photosensitizing antibody-phuorophore conjugates
03/07/2013US20130061338 Screening of drug for attention deficit hyperactive disorder by using git1 knock-out mice as a novel adhd mouse model
03/07/2013US20130058874 Chemical exchange saturation transfer based mri using reporter genes and mri methods related thereto
03/07/2013US20130058873 P97 fragments with transfer activity
03/07/2013US20130058872 Bioluminescent Endoscopy Methods and Compounds
03/07/2013US20130058871 Method and system for mapping synaptic connectivity using light microscopy
03/07/2013US20130058870 3d nanocrystals and manufacturing methods
03/07/2013US20130058869 Prevention And Treatment Of Amyloidogenic Disease
03/07/2013US20130058868 Method for the treatment of t cell mediated conditions by depletion of icos-positive cells in vivo
03/07/2013US20130058867 Solid composition for the oral administration of dyes and diagnostic use thereof
03/07/2013US20130058865 99mTc-LABELED 19 AMINO ACID CONTAINING PEPTIDE FOR USE AS PHOSPHATIDYLETHANOLAMINE BINDING MOLECULAR PROBE AND RADIOPHARMACEUTICAL
03/06/2013EP2564875A1 Liquid preparation for oral administration which can be used in ct colonography, and composition for imaging of digestive tract
03/06/2013EP2563817A2 Fluorescent fusion polypeptides and methods of use
03/06/2013EP2563816A1 Anti-icam-1 single domain antibody and uses thereof
03/06/2013EP2563753A1 Fused cyclooctyne compounds and their use in metal-free click reactions
03/06/2013EP2563408A2 Ultrafine nanoparticles comprising a functionalized polyorganosiloxane matrix and including metal complexes; method for obtaining same and uses thereof in medical imaging and/or therapy
03/06/2013EP2563407A1 Diagnostic reagents
03/06/2013CN1993147B Ultrasonic contrast agent dosage formulation
03/06/2013CN102958509A Polymeric system for delivering preservative-free prostaglandin-based nonviscous solution
03/06/2013CN102949734A Traditional Chinese medicine gastrointestinal auxiliary for type-B ultrasonic and preparation method thereof
03/06/2013CN102397566B Adapter-modified magneto-optic dual-function contrast agent and preparation method and application thereof
03/06/2013CN102397561B Application of mitoxantrone as lymph tracer
03/06/2013CN102370994B Penicillin drug skin test reagent and preparation method thereof
03/06/2013CN101987202B Preparation of dendrimer/ gold-silver alloy nanoparticle with computed tomography (CT) radiography function
03/06/2013CN101979096B Gold and iodine element-supported arborescent macromolecular computed tomography (CT) targeted contrast medium and preparation thereof
03/06/2013CN101466410B Novel therapeutic and diagnostic products and methods
03/05/2013US8389792 Compositions and methods for the treatment and prevention of ulcerative colitis and colon cancer and screening methods to identify same
03/05/2013US8389043 Preparation for restenosis prevention
03/05/2013US8388977 Diagnosis of macrophage mediated disease
03/05/2013US8388935 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
03/05/2013US8388934 Diagnostic agent
03/05/2013US8388933 Multimeric protein toxins to target cells having multiple identifying characteristics
03/05/2013US8388930 Diagnosis and assessment of skeletal related disease using calcium 41
02/2013
02/28/2013WO2013028791A1 18f compounds for cancer imaging and methods for their use
02/28/2013WO2013027694A1 Molecular imaging probes for diagnosing conformation disease
02/28/2013US20130055417 Hormone responsive tissue culture system and uses thereof
02/28/2013US20130052203 In vivo screening models for treatment of qc-related disorders
02/28/2013US20130052143 Liquid preparation for oral administration to be used in ct colonography, and composition for digestive tract imaging
02/28/2013US20130052142 Loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
02/28/2013US20130052141 Hyperpolarized lactate contrast agent for determination of ldh activity
02/28/2013US20130052140 Fe3o4/tio2 composite nano-particle, its preparation and application in magnetic resonance imaging contrast agents
02/28/2013US20130052139 Method and kit for quantifying risk predictor
02/28/2013US20130052138 Methods and compositions for diagnostic and therapeutic targeting of cox-2
02/28/2013US20130052137 Para amino benzoic acid based nanotubes
02/28/2013US20130052136 Methods and apparatuses for predicting the effects of erythropoiesis stimulating agents, and for determining a dose to be administered
02/28/2013US20130052135 Molecules With Extended Half-Lives, Compositions And Uses Thereof
02/28/2013US20130052134 Peg-plga-pll polymer and method for preparing and using the same as the drug and gene carrier
02/28/2013US20130052131 Nanoparticles, methods of making nanoparticles, and methods of use
02/27/2013EP2560978A1 Inhibitors of arginase and their therapeutic applications
02/27/2013EP2560687A2 Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types
02/27/2013EP2560674A2 Nanoparticle targeting to ischemia for imaging and therapy
02/27/2013CN102940895A Nanobubble solution, preparation method and applications thereof
02/27/2013CN102940894A Preparation of targeted CT (computed tomography) contrast agent of second generation polyamide-amine dendrimer stabilized gold nanoparticle based on folate modification
02/27/2013CN102940893A Contrast agent having two functions of up-conversion luminescence and magnetic resonance imaging, and method for preparing same
02/27/2013CN102940892A Preparation method of targeting porphyrin fluorescent molecule and gold nanorod dyad
02/27/2013CN102940891A Lipids, lipid complexes and use thereof
02/27/2013CN102940537A Method for building small pig model for research on lower limb deep venous thrombus formation and pulmonary embolism
02/27/2013CN102160894B Benzamide analog mediated brain-targeting delivery system
02/26/2013US8383408 Nanofibrillar structure and applications including cell and tissue culture
02/26/2013US8383354 Diagnostic method for atherosclerosis
02/26/2013US8383158 Methods and compositions to treat myocardial conditions
02/26/2013US8383116 Anti-leukocyte recruitment therapy for the treatment of seizures and epilepsy
02/26/2013US8383085 Methods of making iron-containing nanoparticles
02/26/2013US8383084 Modify surface of spore to increase adherence to phagocyte; activate phagocytic cells; ingest spore with phagocyte; killing spore by blocking spore-induced phagocyte cell death; increase activation, production of antimicrobial and cytocidal agents endogenous nitric oxide, inflammatory cytokines
02/26/2013CA2327586C Fap.alpha.-specific antibody with improved producibility
02/26/2013CA2324648C Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
02/25/2013CA2750419A1 Novel treatment, prevention or diagnosis of health problems
02/21/2013WO2013025885A1 Detection of hydrogen peroxide
02/21/2013WO2013023795A1 Compounds for binding to the platelet specific glycoprotein iib/iiia and their use for imaging of thrombi
02/21/2013WO2012118715A9 Non-peptidic quenched fluorescent imaging probes
02/21/2013US20130045960 Abuse-Deterrent Pharmaceutical Compositions of Opiods and Other Drugs
02/21/2013US20130045168 Radiographic contrast agent for postmortem, experimental and diagnostic angiography
02/21/2013US20130045167 Staining Composition
02/21/2013US20130045166 Methods of Polynucleotide Detection
02/21/2013US20130045161 Methods and compositions for targeted imaging
02/21/2013CA2846240A1 Antibodies that bind integrin alpha-v beta-8
02/21/2013CA2845477A1 Compounds for binding to the platelet specific glycoprotein iib/iiia and their use for imaging of thrombi
02/20/2013CN102939538A Diagnostic method for the detection of cells ex vivo
02/20/2013CN102936600A A549 nude mouse model of stably expressed luciferase and building and application thereof
02/20/2013CN102936283A Anti-human CD146 monoclonal antibodies, compositions containing anti-human CD146 monoclonal antibodies, and soluble CD146 detection method
02/20/2013CN102935242A Traditional Chinese medicine-assisted imaging preparation for ultrasonic image diagnosis, and preparation method thereof
02/20/2013CN102935241A Magnetic resonance imaging (MRI) contrast agent for breast cancer diagnosis and preparation method thereof
02/20/2013CN102935067A Stealth liposome having PVTRPPR fragment modification on surface, preparation method and uses thereof
02/20/2013CN101608212B Application of schizandrin A in detection of cytochrome P4503A enzymatic activity and detection method thereof
02/20/2013CN101065153B Radiopaque polymeric stents
02/19/2013US8380282 Method for acquiring electromagnetic signals and contrast product therefor
02/19/2013US8377649 Methods for diagnosis of myelodysplastic syndromes (MDS)
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 354